Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Actavis has started supplying Oxymorphone Hydrochloride extended-release (ER) tablets, CII 7.5mg and 15mg in the US.
Subscribe to our email newsletter
The company’s Oxymorphone Hydrochloride ER tablets, CII are the generic version of Opana ER.
Opana ER is indicated for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.
Actavis Sales & Marketing vice president Michael Perfetto said Oxymorphone ER tablets offer significant value to customers and patients.
"This launch exemplifies Actavis’ focus, commitment and capability in bringing complex controlled-release products to our customers," Perfetto said.